{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:50:49Z","timestamp":1790985049742,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007249","name":"University of Minnesota Twin Cities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007249","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.yexmp.2022.104761","type":"journal-article","created":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T10:56:23Z","timestamp":1649069783000},"page":"104761","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Differential expression of preferentially expressed antigen in melanoma (PRAME) in testicular germ cell tumors \u2013 A comparative study with SOX17"],"prefix":"10.1016","volume":"126","author":[{"given":"Yan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimi","family":"Rothrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paari","family":"Murugan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faqian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexmp.2022.104761_bb0005","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1002\/1097-0142(20011201)92:11<2778::AID-CNCR10125>3.0.CO;2-S","article-title":"MAGE-A4, a germ cell specific marker, is expressed differentially in testicular tumors","volume":"92","author":"Aubry","year":"2001","journal-title":"Cancer."},{"key":"10.1016\/j.yexmp.2022.104761_bb0010","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1046\/j.1365-2141.1998.00982.x","article-title":"PRAME, a gene encoding an antigen recognized on a human melanoma by cytolytic T cells, is expressed in acute leukaemia cells","volume":"102","author":"van Baren","year":"1998","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.yexmp.2022.104761_bb0015","first-page":"359","article-title":"Genome-wide expression profiling reveals new insights into pathogenesis and progression of testicular germ cell tumors","volume":"4","author":"Biermann","year":"2007","journal-title":"Cancer Genomics Proteomics"},{"key":"10.1016\/j.yexmp.2022.104761_bb0020","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/modpathol.2011.6","article-title":"MAGEC2 is a sensitive and novel marker for seminoma: a tissue microarray analysis of 325 testicular germ cell tumors","volume":"24","author":"Bode","year":"2011","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.yexmp.2022.104761_bb0025","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/modpathol.2013.183","article-title":"Cancer testis antigen expression in testicular germ cell tumorigenesis","volume":"27","author":"Bode","year":"2014","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.yexmp.2022.104761_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2019.104293","article-title":"Wnt suppressor and stem cell regulator TCF7L1 is a sensitive immunohistochemical marker to differentiate testicular seminoma from non-seminomatous germ cell tumor","volume":"110","author":"Bu","year":"2019","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.yexmp.2022.104761_bb0035","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.humpath.2016.08.002","article-title":"Perspectives on testicular germ cell neoplasms","volume":"59","author":"Cheng","year":"2017","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.yexmp.2022.104761_bb0040","first-page":"974","article-title":"MAGE-1 and MAGE-3 tumor rejection antigens in human germ cell tumors","volume":"12","author":"Cheville","year":"1999","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.yexmp.2022.104761_bb0045","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1158\/1078-0432.CCR-15-2071","article-title":"PRAME as an independent biomarker for metastasis in Uveal melanoma","volume":"22","author":"Field","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexmp.2022.104761_bb0050","doi-asserted-by":"crossref","first-page":"595","DOI":"10.5858\/arpa.2013-0566-CP","article-title":"Template for reporting results of biomarker testing of specimens from patients with carcinoma of the breast","volume":"138","author":"Fitzgibbons","year":"2014","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.yexmp.2022.104761_bb0055","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0090-4295(98)00618-9","article-title":"Expression of MAGE genes in testicular germ cell tumors","volume":"53","author":"Hara","year":"1999","journal-title":"Urology."},{"key":"10.1016\/j.yexmp.2022.104761_bb0060","doi-asserted-by":"crossref","first-page":"20422","DOI":"10.1073\/pnas.0810777105","article-title":"Genome-wide analysis of cancer\/testis gene expression","volume":"105","author":"Hofmann","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexmp.2022.104761_bb0070","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1074-7613(00)80426-4","article-title":"Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor","volume":"6","author":"Ikeda","year":"1997","journal-title":"Immunity."},{"key":"10.1016\/j.yexmp.2022.104761_bb0075","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/path.2332","article-title":"Differential expression of SOX17 and SOX2 in germ cells and stem cells has biological and clinical implications","volume":"215","author":"de Jong","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/j.yexmp.2022.104761_bb0080","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/S0002-9440(10)63602-4","article-title":"Identical allelic losses in mature teratoma and other histologic components of malignant mixed germ cell tumors of the testis","volume":"163","author":"Kernek","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.yexmp.2022.104761_bb0085","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1097\/PAS.0000000000001134","article-title":"PRAME expression in melanocytic tumors","volume":"42","author":"Lezcano","year":"2018","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.yexmp.2022.104761_bb0090","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/1097-0215(20000701)87:1<55::AID-IJC8>3.0.CO;2-J","article-title":"MAGE-B5, MAGE-B6, MAGE-C2, and MAGE-C3: four new members of the MAGE family with tumor-specific expression","volume":"87","author":"Lucas","year":"2000","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.yexmp.2022.104761_bb0095","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/1097-0142(19890801)64:3<715::AID-CNCR2820640325>3.0.CO;2-I","article-title":"Intratubular germ cell neoplasia in testicular teratomas and epidermoid cysts. Correlation with prognosis and possible biologic significance","volume":"64","author":"Manivel","year":"1989","journal-title":"Cancer."},{"key":"10.1016\/j.yexmp.2022.104761_bb0100","series-title":"Testicular Cancer (Version 2.2021)","author":"National Comprehensive Cancer Network","year":"2021"},{"key":"10.1016\/j.yexmp.2022.104761_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005415","article-title":"BMP inhibition in seminomas initiates Acquisition of Pluripotency via NODAL signaling resulting in reprogramming to an Embryonal carcinoma","volume":"11","author":"Nettersheim","year":"2015","journal-title":"PLoS Genet."},{"key":"10.1016\/j.yexmp.2022.104761_bb0110","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/bjc.2016.187","article-title":"The cancer\/testis-antigen PRAME supports the pluripotency network and represses somatic and germ cell differentiation programs in seminomas","volume":"115","author":"Nettersheim","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.yexmp.2022.104761_bb0115","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1309\/AJCP7MNCNBCRN8NO","article-title":"Differential expression of SOX2 and SOX17 in testicular germ cell tumors","volume":"131","author":"Nonaka","year":"2009","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.yexmp.2022.104761_bb0120","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1158\/1078-0432.CCR-03-0813","article-title":"The tumor-associated antigen PRAME is universally expressed in high-stage neuroblastoma and associated with poor outcome","volume":"10","author":"Oberthuer","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexmp.2022.104761_bb0125","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nrc1568","article-title":"Testicular germ-cell tumours in a broader perspective","volume":"5","author":"Oosterhuis","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yexmp.2022.104761_bb0130","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/s41568-019-0178-9","article-title":"Human germ cell tumours from a developmental perspective","volume":"19","author":"Oosterhuis","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yexmp.2022.104761_bb0135","article-title":"Immunohistochemical expression of preferentially expressed antigen in melanoma (PRAME) in the uninvolved background testis, germ cell Neoplasia in situ, and germ cell tumors of the testis","author":"Ricci","year":"2021","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.yexmp.2022.104761_bb0140","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1097\/PAS.0b013e31802e708a","article-title":"Embryonic stem cell transcription factor signatures in the diagnosis of primary and metastatic germ cell tumors","volume":"31","author":"Santagata","year":"2007","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.yexmp.2022.104761_bb0145","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nrc1669","article-title":"Cancer\/testis antigens, gametogenesis and cancer","volume":"5","author":"Simpson","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yexmp.2022.104761_bb0150","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/s41379-019-0335-4","article-title":"Analyses of molecular and histopathologic features and expression of PRAME by immunohistochemistry in mucosal melanomas","volume":"32","author":"Toyama","year":"2019","journal-title":"Mod. Pathol."},{"issue":"Suppl. 2","key":"10.1016\/j.yexmp.2022.104761_bb0155","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/S0893-3952(22)04459-3","article-title":"Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues","volume":"18","author":"Ulbright","year":"2005","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.yexmp.2022.104761_bb0160","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1097\/PAS.0000000000000233","article-title":"Best practices recommendations in the application of immunohistochemistry in testicular tumors: report from the International Society of Urological Pathology consensus conference","volume":"38","author":"Ulbright","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.yexmp.2022.104761_bb0165","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1056\/NEJMoa021967","article-title":"A gene-expression signature as a predictor of survival in breast cancer","volume":"347","author":"van de Vijver","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexmp.2022.104761_bb0170","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev-pharmtox-011112-140326","article-title":"Cause and consequence of cancer\/testis antigen activation in cancer","volume":"54","author":"Whitehurst","year":"2014","journal-title":"Annu. Rev. Pharmacol. Toxicol."}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480022000211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480022000211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T03:12:17Z","timestamp":1757992337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480022000211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":33,"alternative-id":["S0014480022000211"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2022.104761","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential expression of preferentially expressed antigen in melanoma (PRAME) in testicular germ cell tumors \u2013 A comparative study with SOX17","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2022.104761","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104761"}}